Healthcare Integrated Technologies, Inc.
Healthcare Integrated Technologies, Inc. HITC Peers
See (HITC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HITC | $0.30 | N/A | 52.84M | -14.75 | -$0.02 | N/A |
| PMCUF | $175.77 | -0.00% | 18.36B | 292.95 | $0.60 | +0.11% |
| MTHRY | $6.78 | +1.80% | 9.21B | 32.29 | $0.21 | N/A |
| MTHRF | $12.95 | N/A | 8.79B | 31.59 | $0.41 | +0.01% |
| PANHF | $0.90 | N/A | 1.94B | 89.70 | $0.01 | +138.97% |
| CMPUY | $24.63 | -0.02% | 1.27B | 42.46 | $0.58 | N/A |
| PIAHY | $2.29 | N/A | 1.24B | 114.50 | $0.02 | +217.08% |
| CMPVF | $23.85 | +0.02% | 1.23B | 41.13 | $0.58 | +5.39% |
| RSLBF | $32.19 | -0.02% | 1.10B | 48.04 | $0.67 | +0.97% |
| CRWRF | $27.32 | N/A | 956.72M | 63.53 | $0.43 | +1.38% |
Stock Comparison
HITC vs PMCUF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, PMCUF has a market cap of 18.36B. Regarding current trading prices, HITC is priced at $0.30, while PMCUF trades at $175.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas PMCUF's P/E ratio is 292.95. In terms of profitability, HITC's ROE is -1.29%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, HITC is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs MTHRY Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MTHRY has a market cap of 9.21B. Regarding current trading prices, HITC is priced at $0.30, while MTHRY trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MTHRY's P/E ratio is 32.29. In terms of profitability, HITC's ROE is -1.29%, compared to MTHRY's ROE of +0.09%. Regarding short-term risk, HITC is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs MTHRF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MTHRF has a market cap of 8.79B. Regarding current trading prices, HITC is priced at $0.30, while MTHRF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MTHRF's P/E ratio is 31.59. In terms of profitability, HITC's ROE is -1.29%, compared to MTHRF's ROE of +0.09%. Regarding short-term risk, HITC is more volatile compared to MTHRF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs PANHF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, PANHF has a market cap of 1.94B. Regarding current trading prices, HITC is priced at $0.30, while PANHF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas PANHF's P/E ratio is 89.70. In terms of profitability, HITC's ROE is -1.29%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, HITC is less volatile compared to PANHF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CMPUY Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CMPUY has a market cap of 1.27B. Regarding current trading prices, HITC is priced at $0.30, while CMPUY trades at $24.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CMPUY's P/E ratio is 42.46. In terms of profitability, HITC's ROE is -1.29%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, HITC is less volatile compared to CMPUY. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs PIAHY Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, PIAHY has a market cap of 1.24B. Regarding current trading prices, HITC is priced at $0.30, while PIAHY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas PIAHY's P/E ratio is 114.50. In terms of profitability, HITC's ROE is -1.29%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, HITC is less volatile compared to PIAHY. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CMPVF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CMPVF has a market cap of 1.23B. Regarding current trading prices, HITC is priced at $0.30, while CMPVF trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CMPVF's P/E ratio is 41.13. In terms of profitability, HITC's ROE is -1.29%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, HITC is more volatile compared to CMPVF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs RSLBF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, RSLBF has a market cap of 1.10B. Regarding current trading prices, HITC is priced at $0.30, while RSLBF trades at $32.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas RSLBF's P/E ratio is 48.04. In terms of profitability, HITC's ROE is -1.29%, compared to RSLBF's ROE of +0.26%. Regarding short-term risk, HITC is less volatile compared to RSLBF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CRWRF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CRWRF has a market cap of 956.72M. Regarding current trading prices, HITC is priced at $0.30, while CRWRF trades at $27.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CRWRF's P/E ratio is 63.53. In terms of profitability, HITC's ROE is -1.29%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, HITC is more volatile compared to CRWRF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs SUSRF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, SUSRF has a market cap of 790.91M. Regarding current trading prices, HITC is priced at $0.30, while SUSRF trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas SUSRF's P/E ratio is 55.36. In terms of profitability, HITC's ROE is -1.29%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, HITC is more volatile compared to SUSRF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs SMSZF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, SMSZF has a market cap of 727.28M. Regarding current trading prices, HITC is priced at $0.30, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas SMSZF's P/E ratio is 17.47. In terms of profitability, HITC's ROE is -1.29%, compared to SMSZF's ROE of +0.20%. Regarding short-term risk, HITC is more volatile compared to SMSZF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs KSIOF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, KSIOF has a market cap of 451.22M. Regarding current trading prices, HITC is priced at $0.30, while KSIOF trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas KSIOF's P/E ratio is -239.00. In terms of profitability, HITC's ROE is -1.29%, compared to KSIOF's ROE of -0.05%. Regarding short-term risk, HITC is more volatile compared to KSIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs VHIBF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, VHIBF has a market cap of 396.84M. Regarding current trading prices, HITC is priced at $0.30, while VHIBF trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas VHIBF's P/E ratio is 245.00. In terms of profitability, HITC's ROE is -1.29%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, HITC is more volatile compared to VHIBF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs SMDCF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, SMDCF has a market cap of 280.87M. Regarding current trading prices, HITC is priced at $0.30, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, HITC's ROE is -1.29%, compared to SMDCF's ROE of N/A. Regarding short-term risk, HITC is more volatile compared to SMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs DLHTF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, DLHTF has a market cap of 254.80M. Regarding current trading prices, HITC is priced at $0.30, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, HITC's ROE is -1.29%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, HITC is more volatile compared to DLHTF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs VPAHF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, VPAHF has a market cap of 188.24M. Regarding current trading prices, HITC is priced at $0.30, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, HITC's ROE is -1.29%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, HITC is more volatile compared to VPAHF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs COGZF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, COGZF has a market cap of 148.50M. Regarding current trading prices, HITC is priced at $0.30, while COGZF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas COGZF's P/E ratio is 21.75. In terms of profitability, HITC's ROE is -1.29%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, HITC is more volatile compared to COGZF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs ACMLF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ACMLF has a market cap of 130.74M. Regarding current trading prices, HITC is priced at $0.30, while ACMLF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ACMLF's P/E ratio is 30.33. In terms of profitability, HITC's ROE is -1.29%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, HITC is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs ONVVF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ONVVF has a market cap of 127.99M. Regarding current trading prices, HITC is priced at $0.30, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, HITC's ROE is -1.29%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, HITC is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CSAMF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CSAMF has a market cap of 98.80M. Regarding current trading prices, HITC is priced at $0.30, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, HITC's ROE is -1.29%, compared to CSAMF's ROE of -1.58%. Regarding short-term risk, HITC is more volatile compared to CSAMF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs MDPEF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MDPEF has a market cap of 61.28M. Regarding current trading prices, HITC is priced at $0.30, while MDPEF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MDPEF's P/E ratio is 6.00. In terms of profitability, HITC's ROE is -1.29%, compared to MDPEF's ROE of N/A. Regarding short-term risk, HITC is less volatile compared to MDPEF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs RQHTF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, RQHTF has a market cap of 29.97M. Regarding current trading prices, HITC is priced at $0.30, while RQHTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, HITC's ROE is -1.29%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, HITC is less volatile compared to RQHTF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs VASO Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, VASO has a market cap of 23.37M. Regarding current trading prices, HITC is priced at $0.30, while VASO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas VASO's P/E ratio is 13.30. In terms of profitability, HITC's ROE is -1.29%, compared to VASO's ROE of +0.04%. Regarding short-term risk, HITC is more volatile compared to VASO. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs RTNXF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, RTNXF has a market cap of 22.55M. Regarding current trading prices, HITC is priced at $0.30, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, HITC's ROE is -1.29%, compared to RTNXF's ROE of +2.93%. Regarding short-term risk, HITC is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs HDSLF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, HDSLF has a market cap of 21.13M. Regarding current trading prices, HITC is priced at $0.30, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, HITC's ROE is -1.29%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, HITC is more volatile compared to HDSLF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs TREIF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, TREIF has a market cap of 19.14M. Regarding current trading prices, HITC is priced at $0.30, while TREIF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas TREIF's P/E ratio is -2.75. In terms of profitability, HITC's ROE is -1.29%, compared to TREIF's ROE of -11.21%. Regarding short-term risk, HITC is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs THKKF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, THKKF has a market cap of 17.81M. Regarding current trading prices, HITC is priced at $0.30, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas THKKF's P/E ratio is -1.51. In terms of profitability, HITC's ROE is -1.29%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, HITC is more volatile compared to THKKF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs DGNOF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, DGNOF has a market cap of 16.82M. Regarding current trading prices, HITC is priced at $0.30, while DGNOF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas DGNOF's P/E ratio is -5.50. In terms of profitability, HITC's ROE is -1.29%, compared to DGNOF's ROE of +2.18%. Regarding short-term risk, HITC is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs MNNDF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MNNDF has a market cap of 14.25M. Regarding current trading prices, HITC is priced at $0.30, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, HITC's ROE is -1.29%, compared to MNNDF's ROE of N/A. Regarding short-term risk, HITC is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs UDOCF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, UDOCF has a market cap of 14.11M. Regarding current trading prices, HITC is priced at $0.30, while UDOCF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas UDOCF's P/E ratio is -3.08. In terms of profitability, HITC's ROE is -1.29%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, HITC is more volatile compared to UDOCF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs AIMLF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, AIMLF has a market cap of 11.39M. Regarding current trading prices, HITC is priced at $0.30, while AIMLF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas AIMLF's P/E ratio is -1.64. In terms of profitability, HITC's ROE is -1.29%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, HITC is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CRVW Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CRVW has a market cap of 9.93M. Regarding current trading prices, HITC is priced at $0.30, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CRVW's P/E ratio is -1.70. In terms of profitability, HITC's ROE is -1.29%, compared to CRVW's ROE of +0.16%. Regarding short-term risk, HITC is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs PBSV Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, PBSV has a market cap of 9.86M. Regarding current trading prices, HITC is priced at $0.30, while PBSV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas PBSV's P/E ratio is -21.50. In terms of profitability, HITC's ROE is -1.29%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, HITC is more volatile compared to PBSV. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs HSCHF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, HSCHF has a market cap of 9.50M. Regarding current trading prices, HITC is priced at $0.30, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas HSCHF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, HITC is more volatile compared to HSCHF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs VYND Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, VYND has a market cap of 9.16M. Regarding current trading prices, HITC is priced at $0.30, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas VYND's P/E ratio is -49.99. In terms of profitability, HITC's ROE is -1.29%, compared to VYND's ROE of +0.48%. Regarding short-term risk, HITC is more volatile compared to VYND. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs HBCNF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, HBCNF has a market cap of 8.44M. Regarding current trading prices, HITC is priced at $0.30, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, HITC's ROE is -1.29%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, HITC is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs SPLTF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, SPLTF has a market cap of 7.95M. Regarding current trading prices, HITC is priced at $0.30, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, HITC's ROE is -1.29%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, HITC is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs EMOR Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, EMOR has a market cap of 7.55M. Regarding current trading prices, HITC is priced at $0.30, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas EMOR's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, HITC is more volatile compared to EMOR. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs CRBKF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CRBKF has a market cap of 6.84M. Regarding current trading prices, HITC is priced at $0.30, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, HITC's ROE is -1.29%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, HITC is more volatile compared to CRBKF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs DOCRF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, DOCRF has a market cap of 6.25M. Regarding current trading prices, HITC is priced at $0.30, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, HITC's ROE is -1.29%, compared to DOCRF's ROE of -1.25%. Regarding short-term risk, HITC is more volatile compared to DOCRF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs CMPD Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CMPD has a market cap of 5.03M. Regarding current trading prices, HITC is priced at $0.30, while CMPD trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CMPD's P/E ratio is -14.74. In terms of profitability, HITC's ROE is -1.29%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, HITC is more volatile compared to CMPD. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs CNONF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CNONF has a market cap of 4.99M. Regarding current trading prices, HITC is priced at $0.30, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CNONF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, HITC is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs RYAHF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, RYAHF has a market cap of 4.96M. Regarding current trading prices, HITC is priced at $0.30, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, HITC's ROE is -1.29%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, HITC is more volatile compared to RYAHF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs CDXFF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CDXFF has a market cap of 4.86M. Regarding current trading prices, HITC is priced at $0.30, while CDXFF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CDXFF's P/E ratio is -1.20. In terms of profitability, HITC's ROE is -1.29%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, HITC is less volatile compared to CDXFF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CBDS Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CBDS has a market cap of 4.85M. Regarding current trading prices, HITC is priced at $0.30, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CBDS's P/E ratio is -1.68. In terms of profitability, HITC's ROE is -1.29%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, HITC is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs MDBIF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MDBIF has a market cap of 4.77M. Regarding current trading prices, HITC is priced at $0.30, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MDBIF's P/E ratio is -0.21. In terms of profitability, HITC's ROE is -1.29%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, HITC is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs IQAIF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, IQAIF has a market cap of 4.19M. Regarding current trading prices, HITC is priced at $0.30, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas IQAIF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to IQAIF's ROE of -1.62%. Regarding short-term risk, HITC is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs MITI Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MITI has a market cap of 2.83M. Regarding current trading prices, HITC is priced at $0.30, while MITI trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MITI's P/E ratio is -8.33. In terms of profitability, HITC's ROE is -1.29%, compared to MITI's ROE of -0.05%. Regarding short-term risk, HITC is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CMHSF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CMHSF has a market cap of 2.17M. Regarding current trading prices, HITC is priced at $0.30, while CMHSF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CMHSF's P/E ratio is 1.00. In terms of profitability, HITC's ROE is -1.29%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, HITC is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs EBYH Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, EBYH has a market cap of 2.09M. Regarding current trading prices, HITC is priced at $0.30, while EBYH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas EBYH's P/E ratio is -6.00. In terms of profitability, HITC's ROE is -1.29%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, HITC is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs EKGGF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, EKGGF has a market cap of 1.97M. Regarding current trading prices, HITC is priced at $0.30, while EKGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas EKGGF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to EKGGF's ROE of +0.54%. Regarding short-term risk, HITC is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs LVCE Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, LVCE has a market cap of 1.85M. Regarding current trading prices, HITC is priced at $0.30, while LVCE trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas LVCE's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to LVCE's ROE of N/A. Regarding short-term risk, HITC is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs BNVIF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, BNVIF has a market cap of 1.69M. Regarding current trading prices, HITC is priced at $0.30, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas BNVIF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, HITC is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CSOC Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CSOC has a market cap of 1.55M. Regarding current trading prices, HITC is priced at $0.30, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CSOC's P/E ratio is 0.28. In terms of profitability, HITC's ROE is -1.29%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, HITC is more volatile compared to CSOC. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs CTVEF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CTVEF has a market cap of 1.22M. Regarding current trading prices, HITC is priced at $0.30, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CTVEF's P/E ratio is -0.23. In terms of profitability, HITC's ROE is -1.29%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, HITC is more volatile compared to CTVEF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs MDXL Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MDXL has a market cap of 845013.00. Regarding current trading prices, HITC is priced at $0.30, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MDXL's P/E ratio is -0.10. In terms of profitability, HITC's ROE is -1.29%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, HITC is less volatile compared to MDXL. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs CGNSF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, CGNSF has a market cap of 646113.00. Regarding current trading prices, HITC is priced at $0.30, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas CGNSF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, HITC is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs NEWUF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, NEWUF has a market cap of 624794.00. Regarding current trading prices, HITC is priced at $0.30, while NEWUF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas NEWUF's P/E ratio is -0.63. In terms of profitability, HITC's ROE is -1.29%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, HITC is less volatile compared to NEWUF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs NDATF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, NDATF has a market cap of 593644.00. Regarding current trading prices, HITC is priced at $0.30, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas NDATF's P/E ratio is -0.55. In terms of profitability, HITC's ROE is -1.29%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, HITC is more volatile compared to NDATF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs EVAHF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, EVAHF has a market cap of 545985.00. Regarding current trading prices, HITC is priced at $0.30, while EVAHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas EVAHF's P/E ratio is -4.70. In terms of profitability, HITC's ROE is -1.29%, compared to EVAHF's ROE of +0.29%. Regarding short-term risk, HITC is less volatile compared to EVAHF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs ACHKF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ACHKF has a market cap of 522554.00. Regarding current trading prices, HITC is priced at $0.30, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ACHKF's P/E ratio is -0.07. In terms of profitability, HITC's ROE is -1.29%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, HITC is less volatile compared to ACHKF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs MDNWF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MDNWF has a market cap of 517288.00. Regarding current trading prices, HITC is priced at $0.30, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, HITC's ROE is -1.29%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, HITC is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs MDRM Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MDRM has a market cap of 446418.00. Regarding current trading prices, HITC is priced at $0.30, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MDRM's P/E ratio is -0.35. In terms of profitability, HITC's ROE is -1.29%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, HITC is more volatile compared to MDRM. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs DTRK Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, DTRK has a market cap of 319500.00. Regarding current trading prices, HITC is priced at $0.30, while DTRK trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas DTRK's P/E ratio is -5.00. In terms of profitability, HITC's ROE is -1.29%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, HITC is less volatile compared to DTRK. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs LFCOF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, LFCOF has a market cap of 281984.00. Regarding current trading prices, HITC is priced at $0.30, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, HITC's ROE is -1.29%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, HITC is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs TSTTF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, TSTTF has a market cap of 192075.00. Regarding current trading prices, HITC is priced at $0.30, while TSTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas TSTTF's P/E ratio is -0.07. In terms of profitability, HITC's ROE is -1.29%, compared to TSTTF's ROE of +0.33%. Regarding short-term risk, HITC is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs EWLL Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, EWLL has a market cap of 185077.00. Regarding current trading prices, HITC is priced at $0.30, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas EWLL's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, HITC is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs ALDNF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ALDNF has a market cap of 160415.00. Regarding current trading prices, HITC is priced at $0.30, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ALDNF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, HITC is more volatile compared to ALDNF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs USPS Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, USPS has a market cap of 158503.00. Regarding current trading prices, HITC is priced at $0.30, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas USPS's P/E ratio is -1.00. In terms of profitability, HITC's ROE is -1.29%, compared to USPS's ROE of -0.63%. Regarding short-term risk, HITC is less volatile compared to USPS. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs EMYSF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, EMYSF has a market cap of 151670.00. Regarding current trading prices, HITC is priced at $0.30, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas EMYSF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, HITC is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs NMXS Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, NMXS has a market cap of 116770.00. Regarding current trading prices, HITC is priced at $0.30, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas NMXS's P/E ratio is -0.31. In terms of profitability, HITC's ROE is -1.29%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, HITC is more volatile compared to NMXS. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs PPJE Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, PPJE has a market cap of 92048.00. Regarding current trading prices, HITC is priced at $0.30, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas PPJE's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, HITC is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs DSOL Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, DSOL has a market cap of 88891.00. Regarding current trading prices, HITC is priced at $0.30, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas DSOL's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, HITC is more volatile compared to DSOL. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs NHIQ Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, NHIQ has a market cap of 85161.00. Regarding current trading prices, HITC is priced at $0.30, while NHIQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas NHIQ's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, HITC is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs PASO Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, PASO has a market cap of 74059.00. Regarding current trading prices, HITC is priced at $0.30, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas PASO's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to PASO's ROE of +6.20%. Regarding short-term risk, HITC is more volatile compared to PASO. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs ICCO Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ICCO has a market cap of 71654.00. Regarding current trading prices, HITC is priced at $0.30, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ICCO's P/E ratio is -0.40. In terms of profitability, HITC's ROE is -1.29%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, HITC is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs REFG Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, REFG has a market cap of 60838.00. Regarding current trading prices, HITC is priced at $0.30, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas REFG's P/E ratio is -0.01. In terms of profitability, HITC's ROE is -1.29%, compared to REFG's ROE of +0.01%. Regarding short-term risk, HITC is more volatile compared to REFG. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs SOFE Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, SOFE has a market cap of 45131.00. Regarding current trading prices, HITC is priced at $0.30, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas SOFE's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, HITC is less volatile compared to SOFE. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs HDVY Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, HDVY has a market cap of 41171.00. Regarding current trading prices, HITC is priced at $0.30, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas HDVY's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, HITC is more volatile compared to HDVY. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs IGRW Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, IGRW has a market cap of 39815.00. Regarding current trading prices, HITC is priced at $0.30, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas IGRW's P/E ratio is -0.00. In terms of profitability, HITC's ROE is -1.29%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, HITC is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs WMGR Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, WMGR has a market cap of 36250.00. Regarding current trading prices, HITC is priced at $0.30, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas WMGR's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, HITC is less volatile compared to WMGR. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs SSYNF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, SSYNF has a market cap of 33293.00. Regarding current trading prices, HITC is priced at $0.30, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, HITC's ROE is -1.29%, compared to SSYNF's ROE of N/A. Regarding short-term risk, HITC is more volatile compared to SSYNF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs RVRC Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, RVRC has a market cap of 31411.00. Regarding current trading prices, HITC is priced at $0.30, while RVRC trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas RVRC's P/E ratio is -0.09. In terms of profitability, HITC's ROE is -1.29%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, HITC is less volatile compared to RVRC. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs TTBLF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, TTBLF has a market cap of 26744.00. Regarding current trading prices, HITC is priced at $0.30, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, HITC's ROE is -1.29%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, HITC is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs ORHB Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ORHB has a market cap of 25558.00. Regarding current trading prices, HITC is priced at $0.30, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ORHB's P/E ratio is -0.01. In terms of profitability, HITC's ROE is -1.29%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, HITC is more volatile compared to ORHB. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs NHEL Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, NHEL has a market cap of 16219.00. Regarding current trading prices, HITC is priced at $0.30, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas NHEL's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, HITC is more volatile compared to NHEL. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs FDBH Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, FDBH has a market cap of 15022.00. Regarding current trading prices, HITC is priced at $0.30, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas FDBH's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, HITC is more volatile compared to FDBH. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs HLTT Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, HLTT has a market cap of 10663.00. Regarding current trading prices, HITC is priced at $0.30, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas HLTT's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, HITC is more volatile compared to HLTT. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs MOSTQ Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, MOSTQ has a market cap of 8517.00. Regarding current trading prices, HITC is priced at $0.30, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas MOSTQ's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, HITC is more volatile compared to MOSTQ. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs ACNV Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ACNV has a market cap of 8141.00. Regarding current trading prices, HITC is priced at $0.30, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ACNV's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, HITC is more volatile compared to ACNV. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs AHGIF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, AHGIF has a market cap of 7789.00. Regarding current trading prices, HITC is priced at $0.30, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas AHGIF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, HITC is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs BBLNF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, BBLNF has a market cap of 2561.00. Regarding current trading prices, HITC is priced at $0.30, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas BBLNF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, HITC is more volatile compared to BBLNF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs PCYS Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, PCYS has a market cap of 1105.00. Regarding current trading prices, HITC is priced at $0.30, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas PCYS's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, HITC is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs OLMM Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, OLMM has a market cap of 1005.00. Regarding current trading prices, HITC is priced at $0.30, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas OLMM's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, HITC is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs ETAOF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, ETAOF has a market cap of 512.00. Regarding current trading prices, HITC is priced at $0.30, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas ETAOF's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, HITC is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs LGBI Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, LGBI has a market cap of 50.00. Regarding current trading prices, HITC is priced at $0.30, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas LGBI's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, HITC is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.
HITC vs APYI Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, APYI has a market cap of 34.00. Regarding current trading prices, HITC is priced at $0.30, while APYI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas APYI's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to APYI's ROE of -0.60%. Regarding short-term risk, HITC is more volatile compared to APYI. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs WTEQF Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, WTEQF has a market cap of N/A. Regarding current trading prices, HITC is priced at $0.30, while WTEQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas WTEQF's P/E ratio is 1.78. In terms of profitability, HITC's ROE is -1.29%, compared to WTEQF's ROE of N/A. Regarding short-term risk, HITC is more volatile compared to WTEQF. This indicates potentially higher risk in terms of short-term price fluctuations for HITC.
HITC vs VMCS Comparison
HITC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HITC stands at 52.84M. In comparison, VMCS has a market cap of N/A. Regarding current trading prices, HITC is priced at $0.30, while VMCS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HITC currently has a P/E ratio of -14.75, whereas VMCS's P/E ratio is N/A. In terms of profitability, HITC's ROE is -1.29%, compared to VMCS's ROE of +0.08%. Regarding short-term risk, HITC is less volatile compared to VMCS. This indicates potentially lower risk in terms of short-term price fluctuations for HITC.